Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2012
12/26/2012CN102266426B Drug composition for drug quit
12/26/2012CN102080086B Human miR-133a antisense nucleic acid and application thereof
12/26/2012CN102078028B Cigarette for benefiting gallbladder, reducing blood pressure and giving up smoking and preparation method thereof
12/26/2012CN102008739B Solid refreshment agent
12/26/2012CN101942393B Huperzia serrata endophytic fungus shiraia sp. strain for producing huperzine A
12/26/2012CN101883567B Therapeutic use of diaminophenothiazines
12/26/2012CN101774922B 2,3-dyhydroxyl parabens compound as well as preparation and application thereof
12/26/2012CN101687858B 1, 3-dihydroimidazole- 2 -thione derivatives as inhibitors of dopamine-beta-hydroxylase
12/26/2012CN101530413B Combined medicament for treating headache
12/26/2012CN101528207B Transdermal therapeutic system for administering the active substance buprenorphine
12/26/2012CN101524377B Composite of wall-breaking lucidum spore powder and cyclodextrin and preparation method thereof
12/26/2012CN101372511B Immunogenic peptide composition for the prevention and treatment of alzheimer's disease
12/26/2012CN101365439B Levodopa prodrug mesylate, compositions thereof, and uses thereof
12/26/2012CN101310740B Anti-anxiety compound traditional Chinese medicine and preparation method thereof
12/26/2012CN101210051B Anti-VEGF antibodies
12/25/2012USRE43879 Use of the dextrogyral enantiomer of milnacipran for the preparation of a drug
12/25/2012US8338641 Method for treating atypical facial pain
12/25/2012US8338453 Treatment of progressive neurodegenerative disease with ibudilast
12/25/2012US8338447 Pyrido[3,4-B]indoles and methods of use
12/25/2012US8338442 Remedies for psychoneurosis
12/25/2012US8338396 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
12/25/2012US8338379 Monoclonal antibody and use thereof
12/25/2012US8337899 Solid pharmaceutical dispersions with enhanced bioavailability
12/25/2012US8337884 Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
12/25/2012US8337834 Methods of making enhanced, autologous fat grafts
12/25/2012US8337833 Methods of improving central nervous system functioning
12/25/2012US8337829 Conditioned medium and proliferated cell lines produced therefrom
12/20/2012WO2012174552A2 Cathepsin inhibitors for treating microglia-mediated neuron loss in the central nervous system
12/20/2012WO2012174362A1 Pyrazole derivatives as cannabinoid receptor 1 antagonists
12/20/2012WO2012174123A1 Treatment of psychological trauma
12/20/2012WO2012173952A1 Piperazine derivatives, compositions, and uses related thereto
12/20/2012WO2012173850A1 Bicyclo (3.1.0) hexane- 2, 6 -dicarboxylic acid derivatives as mglu2 receptor agonist
12/20/2012WO2012173808A1 Scyllo-inositol for the treatment of behavioral and psychiatric disorders
12/20/2012WO2012173442A2 Composition containing bee venom phospholipase as an active ingredient treating prion disease
12/20/2012WO2012173319A1 Composition containing bee venom phospholipase as active ingredient for treatment of prion disease
12/20/2012WO2012173219A1 Novel biaryl ether derivative
12/20/2012WO2012173214A1 Azepane compound
12/20/2012WO2012173184A1 Lelia (liposome-based enzyme-linked immunoassay) technique using recombinant proteoliposomes
12/20/2012WO2012173174A1 Azaspiroalkane compound
12/20/2012WO2012173163A1 Crushed cells and composition thereof
12/20/2012WO2012172449A1 Lactams as beta secretase inhibitors
12/20/2012WO2012172093A1 Dihydroindolizine derivate as metabotropic glutamate receptor modulators
12/20/2012WO2012172090A1 Chromane-like cyclic prenylflavonoids for the medical intervention in neurological disorders
12/20/2012WO2012171974A1 Tadalafil for the treatment of dementia
12/20/2012WO2012171653A1 Sarizotan for use in the treatment of attention deficit hyperactivity disorder (adhd)
12/20/2012WO2012171231A1 Uses of protein acrosin and the preparation method thereof
12/20/2012WO2012102529A3 Composition for regulating circadian rhythms, composition for diagnosing circadian rhythm disorders and diagnostic kit
12/20/2012US20120323214 Alzheimer's disease treatment with multiple therapeutic agents delivered to the olfactory region through a special delivery catheter and iontophoresis
12/20/2012US20120323190 Percutaneous Absorption Preparation Comprising Anti-Dementia Drug
12/20/2012US20120323003 Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics
12/20/2012US20120322880 Pharmaceutical Formulations of Modafinil
12/20/2012US20120322879 Use of ci-994 and dinaline for the treatment of memory/cognition and anxiety disorders
12/20/2012US20120322868 Food products, preparation, and therapeutic methods
12/20/2012US20120322865 Sustained polypeptide expression from synthetic, modified rnas and uses thereof
12/20/2012US20120322863 Prevention of and countermeasures against mitochondrial disease
12/20/2012US20120322862 Aptamers to 4-1BB and Their Use in Treating Diseases and Disorders
12/20/2012US20120322861 Compositions and Methods for Treating Diseases
12/20/2012US20120322856 Method for Promoting Angiogenesis, Vascularization, or Vessel Repair or for the Inhibiting Tumor Angiogenesis
12/20/2012US20120322854 Regulation of macrophage activation using mir-125b
12/20/2012US20120322853 Treatment of pancreatic developmental gene related diseases by inhibition of natural antisense transcript to a pancreatic developmental gene
12/20/2012US20120322845 Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotine
12/20/2012US20120322842 Heterocycyl-substituted-alkylaminophenyl derivatives, their preparation and use as medicaments
12/20/2012US20120322840 Transdermally Absorbable Preparation Containing Basic Anti-Inflammatory Analgesic
12/20/2012US20120322838 Epothilone Compounds, Preparation Method and Use Thereof
12/20/2012US20120322832 Nicotinic attenuation of cns inflammation and autoimmunity
12/20/2012US20120322831 Compositions for reducing ab 42 production and their use in treating alzheimer's disease (ad)
12/20/2012US20120322830 Cyclourea Compounds as Calcium Channel Blockers
12/20/2012US20120322826 5-ht4 receptor agonists for the treatment of dementia
12/20/2012US20120322824 Cocaine Antagonist/Antidepressant Pharmaceutical Preparations
12/20/2012US20120322823 Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof
12/20/2012US20120322818 Phycotoxins and uses thereof
12/20/2012US20120322816 Rutaecarpine derivatives for activating cyp1a2 in a subject
12/20/2012US20120322815 Pharmaceutical composition containing a3 adenosine receptor agonist
12/20/2012US20120322813 Rutaecarpine derivatives for treating caffeine toxicity
12/20/2012US20120322812 Rutaecarpine derivatives for treating insomnia
12/20/2012US20120322811 Deuterated 1-piperazino-3-phenyl-indanes for treatment of schizophrenia
12/20/2012US20120322810 New salts
12/20/2012US20120322808 Alpha 4 Beta 2 NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS
12/20/2012US20120322801 Heterocyclic amides as rock inhibitors
12/20/2012US20120322799 Deuterated compounds useful for treating neurodegenerative diseases
12/20/2012US20120322798 Modulators of ATP-Binding Cassette Transporters
12/20/2012US20120322796 Benzocycloheptane and benzoxepine derivatives
12/20/2012US20120322794 Treatment tool and method of gradual withdrawal from benzodiazepine dependency
12/20/2012US20120322793 Protein kinase inhibitors
12/20/2012US20120322790 Pyrazolopiperidine Compounds As CCR1 Receptor Antagonists
12/20/2012US20120322785 Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof
12/20/2012US20120322781 Pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one with improved storage and solubility properties
12/20/2012US20120322779 Estriol Therapy for Autoimmune and Neurodegenerative Diseases and Disorders
12/20/2012US20120322777 Oral Contraceptives to Prevent Pregnancy and Diminish Premenstrual Symptomatology
12/20/2012US20120322761 Heterocyclic cetp inhibitors
12/20/2012US20120322751 use of rhamnolipids as a drug of choice in the case of nuclear disasters in the treatment of the combination radiation injuries and illnesses in humans and animals
12/20/2012US20120322740 Mu opioid receptor agonist analogs of the endomorphins
12/20/2012US20120322736 Methods for treatment of headaches by administration of oxytocin
12/20/2012US20120322732 Conjugates of insulin-like growth factor-1 and poly(ethylene glycol)
12/20/2012US20120322729 High activity growth factor mutants
12/20/2012US20120322727 Pharmaceutical Compositions for Intranasal Administration for the Treatment of Neurodegenerative Disorders
12/20/2012US20120322717 Compounds and assays for controlling Wnt activity
12/20/2012US20120321716 Technology for preventing abuse of solid dosage forms
12/20/2012US20120321713 Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
12/20/2012US20120321710 Controlled Release and Taste Masking Oral Pharmaceutical Composition
1 ... 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 ... 1833